Intellectual Property India Publishes Patent Application for 'Methods Of Treating Cancers Using Isoquinoline Or 6-Aza-Quinoline Derivatives' Filed by Black Diamond Therapeutics, Inc.

MUMBAI, India, June 13 -- Intellectual Property India has published a patent application (202517041430 A) filed by Black Diamond Therapeutics, Inc., Cambridge, U.S.A., on April 29, for 'methods of treating cancers using isoquinoline or 6-aza-quinoline derivatives.'

Inventor(s) include Han, Yoon-Chi; Lin, Tai-An; Shin Ogawa, Luisa; Trombino, Anthony F.; Jurczyk, Agata; Ng, Pui Yee; Yurasov, Sergey; Eathiraj, Sudharshan; Hajdenberg, Julio Jos; and Epstein, David M.

The application for the patent was published on June 13, under issue no. 24/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to methods of treating or preventing cancer using a compound of Formula (0): or a pharmaceutically acceptable salt thereof. The present disclosure also relates to pharmaceutical compositions and pharmaceutical kits suitable for the treatment or prevention."

The patent application was internationally filed on Oct. 13, 2023, under International application No.PCT/US2023/076892.

Disclaimer: Curated by HT Syndication.